October 20, 2026 By Attorney Martin Schmidt 

Ozempic Vision Loss Lawsuit: Get Justice for NAION and Permanent Blindness

Did you develop sudden vision loss after the use of GLP-1 weight loss drugs? The Schmidt National Law Group are currently filing claims. Use the 100% Secure form on this page and get a free case evaluation today.

If you developed sudden vision loss after using Ozempic, you may be eligible to file an Ozempic Vision Loss Lawsuit against the drug’s manufacturer. Recent medical research has revealed a dangerous connection between Ozempic and vision problems, specifically a condition called NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) that can cause permanent blindness. We expect large cash claims from any settlements that may occur.

Schmidt National Law Group has been fighting for pharmaceutical injury victims for over 35 years. Our experienced attorneys have handled pharmaceutical litigation for over 35 years and are prepared to fight your Ozempic Lawsuit. We work on a contingency fee basis, which means you pay nothing unless we win your case.

Get Your Free Case Evaluation, Call 24/7: 1-800-631-5656

✓ No Upfront Costs | ✓ 35+ Years Experience | ✓ Nationwide Representation

Ozempic Vision Loss Lawsuit: “Who Qualifies to File an Ozempic Vision Loss Lawsuit?”

The Ozempic lawsuit eligibility criteria include a diagnosis of NAION and prior use of Ozempic or other GLP-1 medications. You may be eligible to pursue legal action if you meet the following conditions:

You may qualify if you:

• Used Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, or Trulicity
• Were diagnosed with NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy)
• Experienced sudden vision loss in one or both eyes
• Suffered permanent or partial blindness
• Required medical treatment for vision-related complications
• Can demonstrate you used a GLP-1 medication before your vision loss occurred

The Ozempic Vision Loss Lawsuit seeks compensation for individuals who suffered permanent blindness or NAION after taking this diabetes medication. If you experienced Ozempic vision loss, you may be entitled to significant compensation for your injuries.

Time is limited to file your claim. Statutes of limitations vary by state, and waiting too long could prevent you from seeking the justice you deserve.

Understanding NAION: What Happens When Ozempic Causes Vision Loss

NAION stands for Non-Arteritic Anterior Ischemic Optic Neuropathy. This serious eye condition occurs when blood flow to the optic nerve is suddenly reduced or blocked, depriving the nerve of oxygen and causing permanent damage. Medical professionals sometimes refer to NAION as an “eye stroke” because of how quickly and devastatingly it can affect vision.

What makes NAION so dangerous:

NAION typically strikes without warning. Many patients wake up one morning to discover they have lost vision in one eye. There is no pain associated with the condition, which means victims often don’t realize something is wrong until significant damage has already occurred. Once the optic nerve is damaged by NAION, the vision loss is usually permanent and irreversible.

The condition most commonly affects one eye initially, but there is a risk it can later affect the other eye as well. Symptoms include sudden blurry vision, blind spots in your field of vision, difficulty seeing colors, and in severe cases, complete blindness in the affected eye.

Medical Evidence: NAION Caused by Ozempic

Medical research has established that NAION caused by Ozempic occurs at rates 4 to 7 times higher than other medications. A groundbreaking study conducted by researchers at Massachusetts Eye and Ear examined thousands of patients and found alarming connections between GLP-1 medications like Ozempic and this devastating eye condition.

The connection between Ozempic and vision problems was not adequately disclosed to patients or healthcare providers. While Novo Nordisk’s warning labels mentioned “changes in vision” as a potential side effect, they failed to specifically warn about the risk of NAION or permanent blindness. This failure to provide adequate warnings is at the heart of the current litigation.

Ozempic Side Effects: Vision Loss and NAION Risk

While Novo Nordisk disclosed some Ozempic side effects, the company failed to adequately warn patients about the risk of permanent vision loss. Recent research has revealed that Ozempic side effects include a significantly increased risk of NAION, a serious eye condition that can lead to irreversible blindness.

The Massachusetts Eye and Ear Study – Critical Findings:

In 2024, researchers at Harvard’s Massachusetts Eye and Ear published a study in JAMA Ophthalmology that sent shockwaves through the medical community. The study analyzed data from over 37 million patients and revealed disturbing statistics about the connection between semaglutide medications (like Ozempic) and NAION.

Key findings include:

• Patients with type 2 diabetes who used semaglutide medications were approximately 4 times more likely to develop NAION compared to those taking other diabetes medications
• Patients who were overweight or obese and used semaglutide for weight loss were over 7 times more likely to develop NAION compared to those on alternative weight-loss medications
• Among diabetic patients prescribed semaglutide, 8.9% developed NAION over 36 months, compared to just 1.8% of those on other diabetes drugs
• Among patients using semaglutide for weight loss, 6.7% developed NAION over 36 months, compared to only 0.8% of those on other weight-loss medications

Why does Ozempic increase NAION risk?

While researchers are still working to understand the exact biological mechanism, several theories have emerged:

Blood pressure and vascular effects: GLP-1 medications like Ozempic are known to affect blood pressure and how blood vessels regulate flow throughout the body. This may reduce circulation to the optic nerve, which is already vulnerable in some patients.

Rapid blood sugar changes: Ozempic works by rapidly lowering blood sugar levels. This sudden change may disrupt normal blood flow to the optic nerve, potentially triggering NAION in susceptible individuals.

Nerve swelling: Some researchers believe that swelling within the optic nerve itself may compress and close off the small blood vessels that supply it with oxygen and nutrients, effectively starving the nerve.

Patients with certain anatomical features, such as a naturally smaller optic disc (where the nerve connects to the eye), may be at even higher risk when taking these medications.

Understanding the NAION Ozempic Lawsuit: What You Need to Know

The NAION Ozempic Lawsuit is part of a larger multidistrict litigation involving 247 active cases against Novo Nordisk and Eli Lilly. In December 2025, the U.S. Judicial Panel on Multidistrict Litigation (JPML) made the decision to consolidate all Ozempic and GLP-1 vision loss lawsuits into a single MDL for more efficient handling.

Current Status of the Litigation:

The consolidated litigation is formally known as In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation, MDL No. 3163. The case is being heard in the U.S. District Court for the Eastern District of Pennsylvania under U.S. District Judge Karen S. Marston.

As of October 2026, there are 247 active lawsuits pending in this MDL, with new cases being added regularly as more victims come forward. Judge Marston also oversees a separate but related MDL involving gastrointestinal injuries from GLP-1 medications, giving her unique insight into the broader safety concerns surrounding these drugs.

What is an MDL?

A Multidistrict Litigation (MDL) is a special legal procedure used when many people file similar lawsuits against the same defendant(s). Rather than having hundreds of individual cases proceed separately in different courts across the country, the cases are consolidated before one judge for pretrial proceedings. This makes the process more efficient for everyone involved.

However, it’s important to understand that each case in an MDL is still evaluated individually. Your specific injuries, medical history, and damages will be considered on their own merits. You are not simply part of a class action where everyone receives the same settlement amount.

Who are the defendants?

The lawsuits name two major pharmaceutical companies as defendants:

• Novo Nordisk – Manufacturer of Ozempic, Wegovy, and Rybelsus
• Eli Lilly – Manufacturer of Mounjaro and Zepbound

Both companies are accused of failing to adequately warn patients and healthcare providers about the risk of NAION and permanent vision loss associated with their GLP-1 medications.

If you were diagnosed with NAION after taking Ozempic, you should contact an attorney immediately to discuss your NAION Ozempic Lawsuit options. The litigation is actively moving forward, and joining now ensures your case receives the attention it deserves.

Why Choose Schmidt National Law Group for Your Ozempic Vision Loss Case

Schmidt National Law Group is actively filing Ozempic Lawsuit claims for victims nationwide who experienced serious side effects. For over 35 years, we have dedicated our practice to holding powerful pharmaceutical companies accountable when their products harm innocent people. We understand the devastating impact that sudden vision loss can have on your life, your career, and your family.

What sets us apart:

Three Decades of Pharmaceutical Litigation Experience

We have been fighting dangerous drug cases since 1991. Our attorneys have represented thousands of claimants in pharmaceutical litigation, including cases against some of the world’s largest drug manufacturers. We understand the complex medical evidence, the legal strategies pharmaceutical companies use to avoid responsibility, and how to build compelling cases that achieve results.

Proven Track Record of Results

Our firm has secured significant compensation for clients in major pharmaceutical and product liability cases:

• $34,575,000 recovered in Roundup cancer lawsuits
• $12,300,000 recovered in JUUL vaping addiction cases

These results demonstrate our capability to take on major corporations and win substantial compensation for our clients.

Nationwide Representation

While our headquarters is located in San Diego, California, we represent clients across the United States. We work with a network of select law firms throughout the country to ensure you receive experienced legal representation regardless of where you live. The GLP-1 medications lawsuit encompasses multiple drugs including Ozempic, Wegovy, Mounjaro, and Zepbound, and we handle cases involving all of these medications.

No Fees Unless You Win

We work on a contingency fee basis, which means you pay absolutely nothing upfront. There are no hourly fees, no retainer costs, and no out-of-pocket expenses. We only get paid if we successfully recover compensation for you. This arrangement ensures that our interests are completely aligned with yours – we don’t win unless you win.

24/7 Availability

We understand that medical emergencies and legal questions don’t only happen during business hours. That’s why we maintain a 24/7 helpline at 1-800-631-5656. You can also reach us anytime via email at help@nationalinjuryadvocates.com. When you’re dealing with permanent vision loss, you need answers and support immediately, and we’re here to provide both.

Personalized Attention

Despite handling mass tort litigation, we treat every client as the only client we have. You will have direct access to your attorney, regular updates on your case, and personalized attention throughout the legal process. We understand that you’re not just a case number – you’re a person whose life has been forever changed by a dangerous drug.

Active Participation in MDL 3163

We are actively participating in the Ozempic NAION MDL and staying at the forefront of all developments in this litigation. This means we have access to shared discovery, expert witnesses, and legal strategies being developed by the nation’s top pharmaceutical litigation attorneys.

Speak with an Ozempic Attorney Now – Call 1-800-631-5656

GLP-1 Medications Lawsuit: Beyond Ozempic to Wegovy and Mounjaro

The GLP-1 medications lawsuit encompasses multiple drugs including Ozempic, Wegovy, Mounjaro, and Zepbound. All of these medications belong to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). They work by mimicking a natural hormone in your body that helps regulate blood sugar and appetite.

GLP-1 Medications Included in the Litigation:

Ozempic (semaglutide) – Manufactured by Novo Nordisk, approved for type 2 diabetes treatment, widely used off-label for weight loss

Wegovy (semaglutide) – Manufactured by Novo Nordisk, specifically approved for weight management in adults with obesity

Rybelsus (semaglutide) – Manufactured by Novo Nordisk, oral tablet form of semaglutide for type 2 diabetes

Mounjaro (tirzepatide) – Manufactured by Eli Lilly, approved for type 2 diabetes treatment

Zepbound (tirzepatide) – Manufactured by Eli Lilly, approved for chronic weight management

Saxenda (liraglutide) – Manufactured by Novo Nordisk, approved for weight management

Trulicity (dulaglutide) – Manufactured by Eli Lilly, approved for type 2 diabetes

If you used any of these medications and subsequently developed NAION or vision loss, you may have a valid legal claim regardless of which specific drug you took.

Compensation for Ozempic Vision Loss: What Damages Are Available?

Compensation for Ozempic vision loss may include medical expenses, lost wages, pain and suffering, and loss of quality of life. When you file an Ozempic Vision Loss Lawsuit, you may be entitled to recover damages for all the ways this injury has impacted your life.

Types of compensation available:

Medical Expenses

• Emergency room visits and hospitalization
• Ophthalmologist consultations and ongoing eye care
• Diagnostic tests and imaging
• Medications and treatments
• Vision aids and assistive devices
• Future medical care related to your vision loss

Lost Wages and Earning Capacity

• Time missed from work for medical appointments and treatment
• Reduced earning capacity if vision loss prevents you from performing your job
• Loss of future earnings if you can no longer work in your chosen profession
• Retraining costs if you need to change careers due to vision impairment

Pain and Suffering

• Physical pain and discomfort
• Emotional distress and mental anguish
• Depression and anxiety related to vision loss
• Loss of enjoyment of life
• Inability to participate in activities you once loved

Loss of Quality of Life

• Inability to drive or loss of independence
• Difficulty reading, watching television, or using computers
• Challenges with daily activities like cooking, cleaning, and personal care
• Impact on relationships with family and friends
• Loss of ability to enjoy hobbies and recreational activities

Punitive Damages
In cases where the defendant’s conduct was particularly egregious, courts may award punitive damages designed to punish the wrongdoer and deter similar conduct in the future. Given that Novo Nordisk and Eli Lilly allegedly knew or should have known about the NAION risk but failed to adequately warn patients, punitive damages may be possible in some cases.

The exact value of your case will depend on your individual circumstances, including the severity of your vision loss, your age, your occupation, and how the injury has affected your daily life. During your free consultation, our attorneys can provide a more specific assessment of the potential value of your claim.

How to File an Ozempic Vision Loss Lawsuit with Schmidt National Law Group

Learning how to file an Ozempic vision loss lawsuit starts with a free consultation with our experienced pharmaceutical litigation attorneys. We’ve designed our process to be as simple and stress-free as possible, so you can focus on your health while we handle the legal complexities.

Step 1: Free Case Evaluation

Contact us by phone at 1-800-631-5656 or complete the secure form on this page. During your initial consultation, we’ll ask about your medical history, when you used Ozempic or other GLP-1 medications, when you developed vision problems, and your diagnosis. This consultation is completely free and confidential, with no obligation to hire us.

Step 2: Case Investigation

If we determine you have a viable case, we’ll begin gathering evidence to support your claim. This includes obtaining your medical records, prescription history, and documentation of your NAION diagnosis. We’ll also consult with medical experts who can establish the connection between your medication use and your vision loss.

Step 3: Filing Your Lawsuit

Once we’ve built a strong foundation for your case, we’ll file your lawsuit and have it added to MDL 3163. Because your case is part of a multidistrict litigation, you’ll benefit from shared discovery and legal work being done by attorneys across the country, while still maintaining your individual claim.

Step 4: Discovery and Evidence Gathering

During the discovery phase, both sides exchange information and evidence. We’ll work to obtain internal documents from Novo Nordisk and Eli Lilly showing what they knew about NAION risks and when they knew it. We’ll also depose company representatives and gather expert testimony to strengthen your case.

Step 5: Settlement Negotiations or Trial

Many pharmaceutical cases are resolved through settlement negotiations. If the defendants make a fair settlement offer, we’ll present it to you and help you make an informed decision. However, if they refuse to offer adequate compensation, we’re fully prepared to take your case to trial and fight for the justice you deserve.

Throughout this entire process, you’ll have direct access to your attorney and regular updates on your case’s progress. We understand that this is a stressful time, and we’re committed to making the legal process as smooth as possible.

Filing Ozempic Blindness Claims: Your Legal Rights

Attorneys at Schmidt National Law Group are currently accepting Ozempic blindness claims from victims across the United States. If you have suffered partial or complete blindness after using Ozempic or another GLP-1 medication, you have legal rights that deserve protection.

Understanding Your Legal Rights:

When a pharmaceutical company releases a medication to the public, they have a legal duty to adequately warn patients and healthcare providers about known risks and side effects. This duty includes:

• Conducting thorough testing to identify potential adverse effects
• Monitoring post-market data to identify emerging safety concerns
• Updating warning labels when new risks are discovered
• Ensuring that warnings are clear, prominent, and specific

The current litigation alleges that Novo Nordisk and Eli Lilly failed to meet these obligations. Despite evidence suggesting a connection between GLP-1 medications and NAION, the companies’ warning labels only mentioned vague “changes in vision” without specifically alerting patients to the risk of permanent blindness.

Why Timing Matters:

Every state has statutes of limitations that set deadlines for filing personal injury lawsuits. These deadlines vary by state and can be affected by factors like when you discovered your injury or when you learned it was connected to Ozempic. Waiting too long could mean losing your right to seek compensation entirely.

Additionally, evidence can become harder to obtain as time passes. Medical records may be destroyed, witnesses’ memories may fade, and important documents may be lost. Filing your claim sooner rather than later helps ensure we can build the strongest possible case on your behalf.

You Don’t Face This Alone:

Losing your vision is one of the most traumatic experiences a person can endure. The physical, emotional, and financial toll can be overwhelming. But you don’t have to face this challenge alone. Our attorneys have spent decades fighting for people just like you – individuals who trusted a medication to help them, only to suffer devastating consequences.

We’re here to hold these pharmaceutical giants accountable and fight for the compensation you need to move forward with your life.

Frequently Asked Questions About Ozempic Vision Loss Lawsuits

At Schmidt National Law Group, there are no upfront costs to file an Ozempic lawsuit. We work on a contingency fee basis, which means we only get paid if we successfully recover compensation for you. There are no hourly fees, no retainer costs, and no out-of-pocket expenses. If we don’t win your case, you owe us nothing.

Q: How long will my Ozempic lawsuit take?

The timeline for pharmaceutical litigation varies depending on many factors, including the complexity of the case, the number of plaintiffs involved, and whether the case settles or goes to trial. Because your case is part of MDL 3163, some aspects of the litigation will move more quickly due to shared discovery and coordinated legal strategies. However, it’s important to understand that these cases typically take months or even years to resolve. We’ll keep you informed every step of the way and work as efficiently as possible to achieve the best outcome for your case.

Q: What if I used Ozempic for weight loss rather than diabetes?

You can still file a lawsuit regardless of why you were prescribed Ozempic. The research from Massachusetts Eye and Ear actually found that patients using semaglutide for weight loss had an even higher risk of developing NAION (over 7 times more likely) compared to those using it for diabetes (4 times more likely). Whether you used Ozempic for its FDA-approved purpose or off-label for weight loss, you have the same legal rights if you suffered vision loss.

Q: Do I need to have been diagnosed with NAION specifically, or can I file if I just have vision loss?

To have the strongest case, you should have a medical diagnosis of NAION from an ophthalmologist or other eye care specialist. However, if you experienced sudden vision loss after using Ozempic but haven’t been formally diagnosed with NAION, you should still contact us. We can help you get the proper medical evaluation and determine whether you have a viable claim.

Q: I stopped taking Ozempic months ago. Can I still file a lawsuit?

Yes. In fact, many people don’t develop NAION until after they’ve stopped taking the medication. What matters is that you used Ozempic or another GLP-1 medication and subsequently developed vision loss. The timing of when you stopped taking the drug doesn’t necessarily prevent you from filing a claim, though statutes of limitations do apply, so it’s important to act quickly.

Q: What if my vision loss is only partial, not complete blindness?

You can still file a lawsuit even if you haven’t lost all vision in the affected eye. NAION can cause varying degrees of vision loss, from blind spots and blurry vision to complete blindness. Any permanent vision impairment caused by Ozempic may entitle you to compensation.

Q: Will I have to go to court and testify?

Most pharmaceutical cases are resolved through settlement negotiations and never go to trial. However, if your case does proceed to trial, you may be asked to testify about your experience. Our attorneys will thoroughly prepare you for any testimony and be with you every step of the way. Many aspects of the litigation, including depositions and court appearances, can be handled remotely via video conference, minimizing the disruption to your life.

Q: Can I file a lawsuit if my loved one died from complications related to Ozempic?

Yes. If your loved one passed away due to complications from NAION or other Ozempic-related injuries, you may be able to file a wrongful death lawsuit on behalf of their estate. These cases seek compensation for medical expenses, funeral costs, loss of financial support, and loss of companionship. Contact us to discuss your specific situation.

Q: What evidence do I need to file an Ozempic lawsuit?

The most important evidence includes your medical records showing your NAION diagnosis, prescription records proving you used Ozempic or another GLP-1 medication, and documentation of your vision loss and treatment. However, you don’t need to gather all this evidence before contacting us. Our legal team will help obtain the necessary records and build your case.

Q: Are there any Ozempic lawsuit settlements yet?

As of October 2026, the litigation is still in its early stages, and no major settlements have been announced. However, with 247 active cases in the MDL and more being filed regularly, settlement negotiations are likely to begin as the litigation progresses. Our attorneys are actively participating in the MDL and will keep you informed of any settlement developments.

Take Action Now: Your Free Case Evaluation Awaits

If you developed sudden vision loss after using Ozempic, Wegovy, Mounjaro, or any other GLP-1 medication, time is critical. Statutes of limitations are ticking, evidence needs to be preserved, and your legal rights need protection.

Schmidt National Law Group is ready to fight for you.

With over 35 years of pharmaceutical litigation experience, a proven track record of results, and a commitment to personalized client care, we have the knowledge and resources to take on Novo Nordisk and Eli Lilly. We’ve recovered millions for clients in dangerous drug cases, and we’re prepared to do the same for you.

Remember:

• ✓ Free case evaluation with no obligation
• ✓ No fees unless we win your case
• ✓ 24/7 availability for your convenience
• ✓ Nationwide representation
• ✓ Active participation in MDL 3163

Don’t let the pharmaceutical companies get away with putting profits over patient safety. Your vision loss deserves justice, and we’re here to help you get it. Complete the Secure Form for Your Free Case Evaluation

Call Now: 1-800-631-5656 (24/7) Or email us anytime: help@nationalinjuryadvocates.com

Page: Ozempic Vision Loss Lawsuit Settlements & Claims Updated on October 20, 2026.